FAH and melanoma: In melanoma, CDC5L upregulates fumarylacetoacetate hydrolase (FAH) transcription [194], binds the proline-rich receptor-like protein kinase (PERK1) gene promoter, and activates the ERK1/2 and JAK2 pathways in ovarian cancer [195].